JP2010530846A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010530846A5 JP2010530846A5 JP2010510365A JP2010510365A JP2010530846A5 JP 2010530846 A5 JP2010530846 A5 JP 2010530846A5 JP 2010510365 A JP2010510365 A JP 2010510365A JP 2010510365 A JP2010510365 A JP 2010510365A JP 2010530846 A5 JP2010530846 A5 JP 2010530846A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- mol
- reducing sugar
- reducing
- histidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 235000000346 sugar Nutrition 0.000 claims 3
- 239000004067 bulking agent Substances 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94155607P | 2007-06-01 | 2007-06-01 | |
| US96908007P | 2007-08-30 | 2007-08-30 | |
| PCT/US2008/006898 WO2008150479A2 (en) | 2007-06-01 | 2008-05-29 | High temperature stable peptide formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010530846A JP2010530846A (ja) | 2010-09-16 |
| JP2010530846A5 true JP2010530846A5 (cg-RX-API-DMAC7.html) | 2012-07-19 |
Family
ID=40094334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010510365A Pending JP2010530846A (ja) | 2007-06-01 | 2008-05-29 | 高温で安定なペプチド製剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7879805B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2150537A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2010530846A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008260483A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2687246A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009012964A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008150479A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2677045C (en) | 2007-01-31 | 2016-10-18 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
| KR20160061439A (ko) | 2007-03-28 | 2016-05-31 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 스티칭된 폴리펩티드 |
| US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
| CN104398471A (zh) * | 2008-11-28 | 2015-03-11 | Abbvie公司 | 稳定的抗体组合物和用于稳定其的方法 |
| CN104490767A (zh) * | 2009-05-04 | 2015-04-08 | 艾伯维生物技术有限公司 | 人抗TNF-α抗体的稳定高蛋白质浓度制剂 |
| CA2781666C (en) * | 2009-11-23 | 2017-02-21 | Cubist Pharmaceuticals, Inc. | Lipopeptide compositions and related methods |
| ES2543795T3 (es) | 2010-03-31 | 2015-08-21 | Stabilitech Ltd. | Estabilización de partículas virales |
| DK2552478T3 (en) | 2010-03-31 | 2017-03-27 | Stabilitech Ltd | EXCIPIENTS FOR STABILIZING VIRUS PARTICLES |
| WO2011121305A2 (en) | 2010-03-31 | 2011-10-06 | Stabilitech Ltd. | Method for preserving alum adjuvants and alum-adjuvanted vaccines |
| MX355543B (es) | 2010-08-13 | 2018-04-20 | Aileron Therapeutics Inc Star | Macrociclos peptidomiméticos. |
| TWI606840B (zh) | 2010-11-11 | 2017-12-01 | 艾伯維生物技術有限責任公司 | 具有增進高濃度之抗-ＴＮＦα抗體之液體調配物 |
| CN102488886B (zh) * | 2011-09-26 | 2014-03-26 | 上海天伟生物制药有限公司 | 一种低杂质含量的卡泊芬净制剂及其制备方法和用途 |
| CN103386117B (zh) * | 2011-09-26 | 2015-09-30 | 上海天伟生物制药有限公司 | 一种低杂质含量的卡泊芬净制剂及其制备方法和用途 |
| GB201117233D0 (en) | 2011-10-05 | 2011-11-16 | Stabilitech Ltd | Stabilisation of polypeptides |
| RU2639523C2 (ru) | 2011-10-18 | 2017-12-21 | Эйлерон Терапьютикс, Инк. | Пептидомиметические макроциклы и их применение |
| EP2773364A1 (en) * | 2011-11-02 | 2014-09-10 | The University of Chicago | Stable pharmaceutical formulations of growth factor peptides |
| JP6450191B2 (ja) | 2012-02-15 | 2019-01-09 | エイルロン セラピューティクス，インコーポレイテッド | ペプチドミメティック大環状化合物 |
| HK1205454A1 (en) | 2012-02-15 | 2015-12-18 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
| KR20140138900A (ko) * | 2012-03-09 | 2014-12-04 | 온코세라피 사이언스 가부시키가이샤 | 펩티드를 포함한 의약 조성물 |
| JP6148487B2 (ja) * | 2012-05-31 | 2017-06-14 | 久保木 芳徳 | チタン−タンパク質複合体の製造方法 |
| EP2698162A1 (en) * | 2012-08-15 | 2014-02-19 | Credentis AG | Method for producing a composition for treating a tooth lesion |
| US9604919B2 (en) | 2012-11-01 | 2017-03-28 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
| US10251935B2 (en) * | 2012-11-28 | 2019-04-09 | Nono Inc. | Lyophilized formulation comprising tat-NR2B9C, histidine and trehalose |
| GB201406569D0 (en) | 2014-04-11 | 2014-05-28 | Stabilitech Ltd | Vaccine compositions |
| LT3149048T (lt) | 2014-05-28 | 2020-05-11 | Nono Inc. | Tat-nr2b9c chlorido druska |
| WO2016049355A1 (en) * | 2014-09-24 | 2016-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and formulations thereof |
| SG11201702223UA (en) | 2014-09-24 | 2017-04-27 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
| AR103173A1 (es) | 2014-12-22 | 2017-04-19 | Novarits Ag | Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17 |
| EP3294318A4 (en) | 2015-03-20 | 2019-04-03 | Aileron Therapeutics, Inc. | PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF |
| JP2018528217A (ja) | 2015-09-10 | 2018-09-27 | エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | Ｍｃｌ−１のモジュレーターとしてのペプチド模倣大環状分子 |
| GB2562241B (en) | 2017-05-08 | 2022-04-06 | Stabilitech Biopharma Ltd | Vaccine compositions |
| CN109528761A (zh) * | 2018-12-20 | 2019-03-29 | 江西润泽药业有限公司 | 制备钠钾钙镁葡萄糖注射液的方法 |
| JP2023517926A (ja) | 2020-03-12 | 2023-04-27 | バクスター・インターナショナル・インコーポレイテッド | ソルビトールとマンニトールの組み合わせを含むダプトマイシン製剤 |
| IL304283B2 (en) * | 2020-03-31 | 2024-12-01 | 3 D Matrix Ltd | Sterilization of self-assembling peptides by irradiation |
| KR102869156B1 (ko) * | 2021-03-29 | 2025-10-15 | (주)아모레퍼시픽 | 콜라겐 펩티드 안정화용 조성물 및 이를 포함하는 식품 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6372716B1 (en) * | 1994-04-26 | 2002-04-16 | Genetics Institute, Inc. | Formulations for factor IX |
| US6685940B2 (en) * | 1995-07-27 | 2004-02-03 | Genentech, Inc. | Protein formulation |
| US5770700A (en) * | 1996-01-25 | 1998-06-23 | Genetics Institute, Inc. | Liquid factor IX formulations |
| US5763401A (en) * | 1996-07-12 | 1998-06-09 | Bayer Corporation | Stabilized albumin-free recombinant factor VIII preparation having a low sugar content |
| AUPO871997A0 (en) | 1997-08-25 | 1997-09-18 | Csl Limited | Dried biologically or therapeutically active preparations |
| GB9930882D0 (en) * | 1999-12-30 | 2000-02-23 | Nps Allelix Corp | GLP-2 formulations |
| US6689353B1 (en) * | 2000-06-28 | 2004-02-10 | Bayer Pharmaceuticals Corporation | Stabilized interleukin 2 |
| JP2003055257A (ja) * | 2001-08-10 | 2003-02-26 | Nihon Pharmaceutical Co Ltd | 安定な血液凝固第ｘｉｉｉ因子製剤 |
| US20030186891A1 (en) | 2002-02-08 | 2003-10-02 | Toshio Okano | Compositions and methods for treatment of vitamin D deficiency |
| AU2003268380A1 (en) * | 2002-10-04 | 2004-05-04 | Elan Pharma International Limited | Gamma irradiation of solid nanoparticulate active agents |
| US20060008415A1 (en) * | 2004-06-25 | 2006-01-12 | Protein Design Labs, Inc. | Stable liquid and lyophilized formulation of proteins |
| WO2006023665A2 (en) * | 2004-08-17 | 2006-03-02 | Regeneron Pharmaceuticals, Inc. | Il-1 antagonist formulations |
-
2008
- 2008-05-29 MX MX2009012964A patent/MX2009012964A/es active IP Right Grant
- 2008-05-29 JP JP2010510365A patent/JP2010530846A/ja active Pending
- 2008-05-29 EP EP08768001A patent/EP2150537A4/en not_active Withdrawn
- 2008-05-29 US US12/129,504 patent/US7879805B2/en not_active Expired - Fee Related
- 2008-05-29 WO PCT/US2008/006898 patent/WO2008150479A2/en not_active Ceased
- 2008-05-29 CA CA002687246A patent/CA2687246A1/en not_active Abandoned
- 2008-05-29 AU AU2008260483A patent/AU2008260483A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010530846A5 (cg-RX-API-DMAC7.html) | ||
| JP2007262090A5 (cg-RX-API-DMAC7.html) | ||
| JP2011088897A5 (cg-RX-API-DMAC7.html) | ||
| JP2010534684A5 (cg-RX-API-DMAC7.html) | ||
| WO2011008548A8 (en) | Vaccines and compositions against streptococcus pneumoniae | |
| CL2013001586A1 (es) | Composicion microgranular de rapida dispersion que comprende al menos un alcohol de azucar, un sacarido, o una mezcla de estos, al menos un super disgregante y al menos un aditivo multifuncion; comprimido de desintegracion oral que comprende la composicion microgranular y al menos un principio activo; y metodos de fabricacion. | |
| JP2013510216A5 (cg-RX-API-DMAC7.html) | ||
| WO2009048148A1 (ja) | シトルリンおよびアルギニンを含有する即効性血中アルギニン濃度上昇型経口剤 | |
| JP2013507408A5 (cg-RX-API-DMAC7.html) | ||
| JP2009017880A5 (cg-RX-API-DMAC7.html) | ||
| JP2011528897A5 (cg-RX-API-DMAC7.html) | ||
| JP2011526526A5 (cg-RX-API-DMAC7.html) | ||
| JP2012516348A5 (cg-RX-API-DMAC7.html) | ||
| WO2008069911A3 (en) | Dual composition with warming and analgesic effects | |
| JP2012500946A5 (cg-RX-API-DMAC7.html) | ||
| JP2006342148A5 (cg-RX-API-DMAC7.html) | ||
| JP2009242695A5 (cg-RX-API-DMAC7.html) | ||
| WO2010098625A3 (ko) | 약제학적 제제 | |
| Yip | Eco-city: From Concept to Implementation-Case Studies in Shanghai Dongtan and Beijing Changxindian | |
| Levine | Today is a new day | |
| Szurman | Triamcinolone as adjunct to vitreous surgery | |
| JP2007145829A5 (cg-RX-API-DMAC7.html) | ||
| Sapna | Small-Pox: Remedies and diagnosis | |
| 夏增强 | Reflections On Christianity | |
| 明风 | oaching the oaches |